DISCLOSEDQuarterly
Renaissance Technologies
Context Therapeutics Inc · NASDAQ
182,999 sh · $479.5K
Filed 31 Mar 2026SEC 13Fview source
Renaissance Technologies
Context Therapeutics Inc · NASDAQ
182,999 sh · $479.5K
BlackRock
Context Therapeutics Inc · NASDAQ
851,696 sh · $1.7M